These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32129558)

  • 1. Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence.
    Mills L; Lintzeris N; Bruno R; Montebello M; Dunlop A; Deacon RM; Copeland J; Jefferies M; Rivas C; Mammen K
    Drug Alcohol Rev; 2020 May; 39(4):356-364. PubMed ID: 32129558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the concurrent validity, inter-rater reliability and test-re-test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populations.
    Deacon RM; Mammen K; Bruno R; Mills L; Dunlop A; Holmes J; Jefferies M; Hall M; Shakeshaft A; Farrell M; Graham R; Lintzeris N
    Addiction; 2021 May; 116(5):1245-1255. PubMed ID: 33201546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Australian Treatment Outcomes Profile instrument as a clinical tool for older alcohol and other drug clients: A validation study.
    Lintzeris N; Monds LA; Rivas G; Leung S; Withall A; Draper B
    Drug Alcohol Rev; 2016 Nov; 35(6):673-677. PubMed ID: 27072851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation and implementation of the Australian Treatment Outcomes Profile in specialist drug and alcohol settings.
    Ryan A; Holmes J; Hunt V; Dunlop A; Mammen K; Holland R; Sutton Y; Sindhusake D; Rivas G; Lintzeris N
    Drug Alcohol Rev; 2014 Jan; 33(1):33-42. PubMed ID: 24206571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining clinical cutoff scores for the Australian Treatment Outcomes Profile psychological health, physical health and quality of life questions.
    Mammen K; Mills L; Deacon RM; Bruno R; Dunlop A; Holmes J; Luksza J; Shakeshaft A; Farrell M; Lintzeris N
    Drug Alcohol Rev; 2022 Jan; 41(1):106-113. PubMed ID: 34189792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric properties of the CAST and SDS scales in young adult cannabis users.
    Cuenca-Royo AM; Sánchez-Niubó A; Forero CG; Torrens M; Suelves JM; Domingo-Salvany A
    Addict Behav; 2012 Jun; 37(6):709-15. PubMed ID: 22386300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying thresholds for clinically meaningful change among clients of drug and alcohol services using the Australian Treatment Outcomes Profile.
    Deacon RM; Mills L; Bruno R; Mammen K; Dunlop A; Childs S; Shakeshaft A; Holmes J; Lintzeris N
    Addiction; 2023 Dec; 118(12):2457-2465. PubMed ID: 37421220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of online self-report versions of the Australian Treatment Outcome Profile (ATOP) and Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) among people in residential treatment for substance use problems.
    Carlyle M; Walter ZC; Theroux B; Leung J; Hides L
    Addict Behav; 2023 Sep; 144():107756. PubMed ID: 37257357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reliability and validity of the Severity of Dependence Scale for detecting cannabis dependence in psychosis.
    Hides L; Dawe S; Young RM; Kavanagh DJ
    Addiction; 2007 Jan; 102(1):35-40. PubMed ID: 17207121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the validity of the Australian Treatment Outcomes Profile for telephone administration in drug health treatment populations.
    Deacon RM; Mammen K; Holmes J; Dunlop A; Bruno R; Mills L; Graham R; Lintzeris N
    Drug Alcohol Rev; 2020 Jul; 39(5):441-446. PubMed ID: 32395850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: reliability, validity and diagnostic cut-off.
    Martin G; Copeland J; Gates P; Gilmour S
    Drug Alcohol Depend; 2006 Jun; 83(1):90-3. PubMed ID: 16310973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An improved brief measure of cannabis misuse: the Cannabis Use Disorders Identification Test-Revised (CUDIT-R).
    Adamson SJ; Kay-Lambkin FJ; Baker AL; Lewin TJ; Thornton L; Kelly BJ; Sellman JD
    Drug Alcohol Depend; 2010 Jul; 110(1-2):137-43. PubMed ID: 20347232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability and validity of the Severity of Dependence Scale for detecting cannabis dependence in frequent cannabis users.
    van der Pol P; Liebregts N; de Graaf R; Korf DJ; van den Brink W; van Laar M
    Int J Methods Psychiatr Res; 2013 Jun; 22(2):138-43. PubMed ID: 23670783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a mental health subscale from the Quality of Well-Being Self-Administered.
    Sarkin AJ; Groessl EJ; Carlson JA; Tally SR; Kaplan RM; Sieber WJ; Ganiats TG
    Qual Life Res; 2013 Sep; 22(7):1685-96. PubMed ID: 23104088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cannabis Problems Questionnaire: factor structure, reliability, and validity.
    Copeland J; Gilmour S; Gates P; Swift W
    Drug Alcohol Depend; 2005 Dec; 80(3):313-9. PubMed ID: 15916867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric properties of the SF-12 (Hebrew version) in a primary care population in Israel.
    Amir M; Lewin-Epstein N; Becker G; Buskila D
    Med Care; 2002 Oct; 40(10):918-28. PubMed ID: 12395025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric validation of the depression and family functioning scale.
    Williams V; François C; Danchenko N; Nelson L; Williams N; Yarr S; DiBenedetti D; Lançon C
    Curr Med Res Opin; 2016; 32(4):639-50. PubMed ID: 26700415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conceptualizing problematic use of medicinal Cannabis: Development and preliminary validation of a brief screening questionnaire.
    Feingold D; Gliksberg O; Brill S; Amit BH; Lev-Ran S; Kushnir T; Sznitman SR
    Addict Behav; 2024 Nov; 158():108122. PubMed ID: 39128420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a short cannabis problems questionnaire for adolescents in the community.
    Proudfoot H; Vogl L; Swift W; Martin G; Copeland J
    Addict Behav; 2010 Jul; 35(7):734-7. PubMed ID: 20356683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of DSM-IV and ICD-10 cannabis dependence among Australian adults: results from the National Survey of Mental Health and Wellbeing.
    Swift W; Hall W; Teesson M
    Drug Alcohol Depend; 2001 Jul; 63(2):147-53. PubMed ID: 11376919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.